Return On Equity of Protagonist Therapeutics, Inc from 31 Mar 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Protagonist Therapeutics, Inc quarterly and annual Return On Equity in % history and change rate from 31 Mar 2017 to 30 Sep 2025.
  • Protagonist Therapeutics, Inc Return On Equity for the quarter ending 30 Sep 2025 was 7%, a 80% decline year-over-year.
  • Protagonist Therapeutics, Inc annual Return On Equity for 2024 was 48%.
  • Protagonist Therapeutics, Inc annual Return On Equity for 2023 was -27%, a 45% increase from 2022.
  • Protagonist Therapeutics, Inc annual Return On Equity for 2022 was -50%, a 23% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Protagonist Therapeutics, Inc Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 7% -28% -80% 01 Jul 2025 30 Sep 2025
Q2 2025 8% -31% -79% 01 Apr 2025 30 Jun 2025
Q1 2025 9% -34% -79% 01 Jan 2025 31 Mar 2025
Q4 2024 48% +75% 01 Oct 2024 31 Dec 2024
Q3 2024 35% +89% 01 Jul 2024 30 Sep 2024
Q2 2024 39% +96% 01 Apr 2024 30 Jun 2024
Q1 2024 43% +103% 01 Jan 2024 31 Mar 2024
Q4 2023 -27% +22% +45% 01 Oct 2023 31 Dec 2023
Q3 2023 -55% -8% -17% 01 Jul 2023 30 Sep 2023
Q2 2023 -57% -13% -28% 01 Apr 2023 30 Jun 2023
Q1 2023 -59% -21% -56% 01 Jan 2023 31 Mar 2023
Q4 2022 -50% -9% -23% 01 Oct 2022 31 Dec 2022
Q3 2022 -47% -12% -33% 01 Jul 2022 30 Sep 2022
Q2 2022 -44% -14% -45% 01 Apr 2022 30 Jun 2022
Q1 2022 -38% -6% -19% 01 Jan 2022 31 Mar 2022
Q4 2021 -40% -1% -3.4% 01 Oct 2021 31 Dec 2021
Q3 2021 -35% +19% +35% 01 Jul 2021 30 Sep 2021
Q2 2021 -31% +42% +58% 01 Apr 2021 30 Jun 2021
Q1 2021 -32% +71% +69% 01 Jan 2021 31 Mar 2021
Q4 2020 -39% +47% +55% 01 Oct 2020 31 Dec 2020
Q3 2020 -54% +21% +28% 01 Jul 2020 30 Sep 2020
Q2 2020 -72% -10% -16% 01 Apr 2020 30 Jun 2020
Q1 2020 -103% -62% -153% 01 Jan 2020 31 Mar 2020
Q4 2019 -86% -52% -152% 01 Oct 2019 31 Dec 2019
Q3 2019 -75% -51% -211% 01 Jul 2019 30 Sep 2019
Q2 2019 -63% -38% -159% 01 Apr 2019 30 Jun 2019
Q1 2019 -41% -6% -18% 01 Jan 2019 31 Mar 2019
Q4 2018 -34% +13% +28% 01 Oct 2018 31 Dec 2018
Q3 2018 -24% +40% +62% 01 Jul 2018 30 Sep 2018
Q2 2018 -24% +35% +59% 01 Apr 2018 30 Jun 2018
Q1 2018 -34% +40% +53% 01 Jan 2018 31 Mar 2018
Q4 2017 -47% 01 Oct 2017 31 Dec 2017
Q3 2017 -64% 01 Jul 2017 30 Sep 2017
Q2 2017 -59% 01 Apr 2017 30 Jun 2017
Q1 2017 -74% 01 Jan 2017 31 Mar 2017

Protagonist Therapeutics, Inc Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 48% +75% 01 Jan 2024 31 Dec 2024
2023 -27% +22% +45% 01 Jan 2023 31 Dec 2023
2022 -50% -9% -23% 01 Jan 2022 31 Dec 2022
2021 -40% -1% -3.4% 01 Jan 2021 31 Dec 2021
2020 -39% +47% +55% 01 Jan 2020 31 Dec 2020
2019 -86% -52% -152% 01 Jan 2019 31 Dec 2019
2018 -34% +13% +28% 01 Jan 2018 31 Dec 2018
2017 -47% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.